NEW YORK, Jan. 6, 2012 /CNW/ - EMO CAPITAL CORP (EMOE:OTCBB) through its wholly owned subsidiary NuVitality Labs forms strategic alliance with Pershing Processing for global payment processing solution. The relationship with Pershing will allow NuVitality to process in multi currency globally further augmenting the companies strategy of controlling as many aspects as possible in their vertical market.
Pershing Processing is a leading gateway and payment processor, run by experienced processing industry professionals linking customers, merchants, and financial institutions in order to facilitate electronic transactions around the world.
Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "intend", "dramatically" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in Emo Capital's filings with the Securities and Exchange Commission. In addition, such statements could be affected by risks and uncertainties related to the ability of the company to control product demand, market and customer acceptance, competition, pricing and development difficulties, as well as general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on Emo Capital's website does not constitute a part of this release.
For further information:
Phone: (888) 374-2961